
Executive Director, Winton Centre for Risk and Evidence Communication
Publications
How well did experts and laypeople forecast the size of the COVID-19 pandemic?
– PLoS ONE
(2021)
16,
e0250935
(doi: 10.1371/journal.pone.0250935)
Communicating personalized risks from COVID-19: guidelines from an empirical study.
– Royal Society open science
(2021)
8,
201721
(doi: 10.1098/rsos.201721)
Effect of information about COVID-19 vaccine effectiveness and side effects on behavioural intentions: Two online experiments
– Vaccines
(2021)
9,
379
(doi: 10.3390/vaccines9040379)
The effects of quality of evidence communication on perception of public health information about COVID-19: two randomised controlled trials
(2021)
2021.04.07.21255010
(doi: 10.1101/2021.04.07.21255010)
COVID-19 risk perception: A longitudinal analysis of its predictors and associations with health protective behaviours in the United Kingdom
– Journal of Risk Research
(2021)
24,
294
Effect of information about COVID-19 vaccine effectiveness and side effects on behavioural intentions: two online experiments
(2021)
2021.03.19.21253963
(doi: 10.1101/2021.03.19.21253963)
The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis.
– PLoS ONE
(2021)
16,
e0246441
(doi: 10.1371/journal.pone.0246441)
Clinical impact of the Predict Prostate risk communication tool in men newly diagnosed with non-metastatic prostate cancer: a multi-centre randomised controlled trial
– EUROPEAN UROLOGY
(2021)
79,
2021.01.24.21249948
(doi: 10.1101/2021.01.24.21249948)
Predictors of COVID-19 vaccine acceptance across time and countries
(2020)
2020.12.09.20246439
(doi: 10.1101/2020.12.09.20246439)
How do the public interpret COVID-19 swab test results? Comparing the impact of official information about results and reliability used in the UK, US and New Zealand: a randomised, controlled trial
(2020)
2020.12.04.20243840
(doi: 10.1101/2020.12.04.20243840)
- <
- 3 of 6